0
OnSite™ PSA Semi-quantitative Rapid Test Kit, 30 Tests
Catalog No :
CAS Number :
Brand :
In Stock
Specifications:
| Application | Diagnostic Testing | ||
| Storage Temperature | Room Temperature | ||
| Product Type | Test Kit | Forms | Kit with Various components |
| Product Brand | CTK Biotech | ||
| Product Grade | Medical grade | ||
The OnSite PSA Semi-quantitative Rapid Test is a lateral flow chromatographic immunoassay designed for the semi-quantitative detection of prostate specific antigen (PSA) in human serum, plasma, or whole blood at a cut-off value of 4 ng/mL. With an additional reference line at 10 ng/mL, this rapid test provides clear, easy-to-interpret three-line results, supporting early prostate cancer screening and monitoring in both clinical and point-of-care settings.
Key Features
- Semi-quantitative detection of PSA in serum, plasma, and whole blood.
- Cut-off value at 4 ng/mL (clinical reference for prostate cancer screening).
- Reference line at 10 ng/mL for simplified interpretation.
- Three-line test result design enables quick and accurate result analysis.
- Rapid results in minutes, no equipment required.
- Supports non-invasive prostate cancer screening and monitoring.
- Conveniently packaged in individually sealed foil pouches.
Kit Contents
Each kit (30 tests) contains:
- One cassette device (per pouch).
- One desiccant.
- Plastic droppers.
- Sample diluent (REF SB-R2002, 5 mL/bottle).
- Package insert (instructions for use).
Specifications
| Parameter | Details |
|---|---|
| Product Name | PSA Semi-quantitative Rapid Test |
| Catalog Number | R2002C |
| Format | 30 tests/kit |
| Specimen Type | Serum (S), Plasma (P), Whole Blood (WB) |
| Detection | Prostate Specific Antigen (PSA) |
| Principle | Lateral Flow Chromatographic Immunoassay |
| Cut-off Value | 4 ng/mL (screening threshold) |
| Reference Value | 10 ng/mL |
| Result Format | Three-line test for semi-quantitative results |
| Turnaround Time | Rapid results within minutes |
| Packaging | Individually sealed foil pouches with desiccant |
| Regulatory Status | CE-marked |
Applications
- Early screening for prostate cancer in men.
- Monitoring PSA levels for recurrence or progression of prostate disease.
- Point-of-care testing in clinics and urology practices.
- Public health prostate cancer awareness and screening programs.
The OnSite PSA Semi-quantitative Rapid Test provides a fast, non-invasive, and reliable method for prostate cancer screening and monitoring. With its cut-off of 4 ng/mL and reference line at 10 ng/mL, the test delivers easy-to-interpret results, making it an essential diagnostic support tool for clinicians, urologists, and public health screening programs. Its simplicity, semi-quantitative design, and rapid turnaround make it highly suitable for use in both clinical laboratories and field healthcare settings.